Top

31-05-2016 | Obesity | Patient and physician’s perspective | Article

Pharmacotherapy for Obesity and Changes in Eating Behavior: a Patient and Physician’s Perspective

Journal: Advances in Therapy

Authors: Piper L. Miguelgorry, Ed J. Hendricks

Publisher: Springer Healthcare

Abstract

This article, co-authored by a patient with obesity, diabetes, and hypertension, and an obesity medicine specialist, discusses the patient’s experience with the onset of diabetes complicating obesity and with her frustration living with these diagnoses until finding an obesity medicine specialist physician who helped her lose weight and reverse her diabetes. The patient continues to maintain a significant weight loss and is diabetes free for 5.5 years after treatment initiation. The physician discusses the application of combination treatment that can be effective in diabetes reversal in such cases. He also discusses salient clinical lessons exemplified by this case.

Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 2001;161:218–27.CrossRefPubMed

Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008;13:95–101.CrossRefPubMed

Hendricks EJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring). 2011;19:2351–60.CrossRef

Hendricks EJ. Pharmacotherapy, Chapter 8. In: Steelman GM, Westman EC, editors. Obesity, evaluation and treatment essentials. Boca Raton: CRC; 2016. p. 137–67.

Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376:595–605.CrossRefPubMed

Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome. Endocr Res. 2015;40:133–8.CrossRefPubMed

Westman EC, Vernon MC. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design. Nutr Metab (Lond). 2008;5:10.CrossRef

Osler W, McCrae T. Diabetes mellitus dietary treatment. The principles and practice of medicine. Designed for the use of practitioners and students of medicine. New York: Appleton; 1920. p. 431–4.

Steven S, Lim EL, Taylor R. Population response to information on reversibility of type 2 diabetes. Diabet Med. 2013;30(4):e135–8.CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform.

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Medicine Matters Diabetes

Pharmacotherapy for Obesity and Changes in Eating Behavior: a Patient and Physician’s Perspective

Abstract

Be confident that your patient care is up to date

Related content

Brain may put brakes on liraglutide weight loss effect

PIONEER 2, PIONEER 4 show benefits of oral semaglutide in type 2 diabetes

Metformin may help people at high diabetes risk to maintain weight loss